NF2-Related Schwannomatosis (NF2-SWN) is a rare tumor predisposition syndrome characterized by heterogeneous clinical manifestations that substantially impact quality of life (QOL). In this diverse patient population, a disease-specific QOL instrument is essential for both research and clinical decision-making....
No immediate change to audiological practice; the validated Dutch NFTI-QOL questionnaire is now available for use in Dutch-speaking NF2 patient populations to better capture quality-of-life data in clinical and research settings.
Validated, language-specific quality-of-life tools are essential for accurately measuring patient-reported outcomes in rare diseases like NF2-related schwannomatosis, enabling better cross-center research and clinical benchmarking.
- 01Study validates the Dutch version of the NFTI-QOL questionnaire for NF2-related schwannomatosis patients.
- 02Examines determinants — such as hearing loss, balance problems, and pain — that drive quality-of-life differences.
- 03Published in the journal Family Cancer.
- 04NF2-related schwannomatosis typically causes bilateral vestibular schwannomas, leading to profound hearing loss.
- 05Findings support use of this tool in Dutch-speaking clinical and research populations.
The Dutch NFTI-QOL questionnaire is a valid tool for measuring quality of life in NF2-related schwannomatosis patients.
studysupportedSpecific clinical factors are identifiable determinants of quality of life in NF2-related schwannomatosis.
studypartially supported- PMID
- 42313268
- DOI
- 10.1007/s10689-026-00581-0.
- Journal
- Family Cancer
- Publication type
- research_article
- Evidence level
- 2b
- Population
- Patients with NF2-related schwannomatosis, Dutch-speaking cohort
- Intervention
- Administration and validation of the Dutch NFTI-QOL questionnaire
Primary outcomes
Validity and reliability of the Dutch NFTI-QOL questionnaire; Determinants of quality of life in NF2-related schwannomatosis patients